SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000891293-22-000043
Filing Date
2022-08-08
Accepted
2022-08-08 16:32:58
Documents
50
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ctic-20220630.htm   iXBRL 10-Q 942307
2 EX-10.3 baxaltaamendmentno1fully.htm EX-10.3 1558
3 EX-31.1 ex311-ceo302q2fy22.htm EX-31.1 11336
4 EX-31.2 ex312-cfo302q2fy22.htm EX-31.2 12204
5 EX-32 ex32-ceocfo906q2fy22.htm EX-32 11649
11 baxaltaamendmentno1fully001.jpg GRAPHIC 219786
12 baxaltaamendmentno1fully002.jpg GRAPHIC 70004
13 baxaltaamendmentno1fully003.jpg GRAPHIC 151503
14 baxaltaamendmentno1fully004.jpg GRAPHIC 23304
  Complete submission text file 0000891293-22-000043.txt   4756327

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctic-20220630.xsd EX-101.SCH 29088
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctic-20220630_cal.xml EX-101.CAL 44769
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctic-20220630_def.xml EX-101.DEF 171668
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctic-20220630_lab.xml EX-101.LAB 378040
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctic-20220630_pre.xml EX-101.PRE 237370
44 EXTRACTED XBRL INSTANCE DOCUMENT ctic-20220630_htm.xml XML 509285
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28386 | Film No.: 221144891
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences